Industry Research Reports
Home > Reports > Food & Beverages > Global Aflatoxin M1 Immunoaffinity Columns (IAC) Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Aflatoxin M1 Immunoaffinity Columns (IAC) Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Food & Beverages
Published Date: 2025-10-03
Pages: 181 Pages
Report ld: 5169145
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Aflatoxin M1 Immunoaffinity Columns (IAC) market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Aflatoxin B1 Immunoaffinity Columns (IACs) are specialized chromatographic columns designed specifically for the extraction and purification of aflatoxin B1 (AFB1) from various samples. AFB1 is one of the most significant and toxic aflatoxins produced by certain molds, particularly Aspergillus flavus and Aspergillus parasiticus.
From a downstream perspective, Milk accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Aflatoxin M1 Immunoaffinity Columns (IAC) leading manufacturers including Gold Standard Diagnostics Horsham, LCTech, Shimadzu, Biotez Berlin, PerkinElmer, VICAM, Ring Biotechnology, R-Biopharm AG, CHROMATIFIC, Neogen, etc., dominate supply; the top five capture approximately % of global revenue, with Gold Standard Diagnostics Horsham leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Aflatoxin M1 Immunoaffinity Columns (IAC) market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Gold Standard Diagnostics Horsham
- LCTech
- Shimadzu
- Biotez Berlin
- PerkinElmer
- VICAM
- Ring Biotechnology
- R-Biopharm AG
- CHROMATIFIC
- Neogen
- Kwinbon Biotechnology
- Shandong Meizheng Bio-Tech
- Jiangsu Wisdom Engineering & Technology
- BIOCOMMA
- Beijing Nano-Ace Technology
- Femdetection
- Wuhan Huamei Wisherkon Biotech
- Changsha Huaxue Biological Technology
- Anavo
- Shandong Vnya Bio-technology
- Guanyibio
- Prufunglab
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- 80% Below
- 80-90%
- 91-100%
- 100% Above
Segment by Application
- Milk
- Goat Milk
- Soy Milk
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Aflatoxin M1 Immunoaffinity Columns (IAC) study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Aflatoxin M1 Immunoaffinity Columns (IAC): Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 80% Below
1.2.3 80-90%
1.2.4 91-100%
1.2.5 100% Above
1.3 Market Segmentation by Application
1.3.1 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Milk
1.3.3 Goat Milk
1.3.4 Soy Milk
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue Estimates and Forecasts 2020-2031
2.2 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Estimates and Forecasts 2020-2031
2.4 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 80% Below Market Size by Manufacturers
3.5.2 80-90% Market Size by Manufacturers
3.5.3 91-100% Market Size by Manufacturers
3.5.4 100% Above Market Size by Manufacturers
3.6 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Aflatoxin M1 Immunoaffinity Columns (IAC) Sales and Revenue by Type (2020-2031)
6.4 North America Aflatoxin M1 Immunoaffinity Columns (IAC) Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Aflatoxin M1 Immunoaffinity Columns (IAC) Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Aflatoxin M1 Immunoaffinity Columns (IAC) Sales and Revenue by Type (2020-2031)
7.4 Europe Aflatoxin M1 Immunoaffinity Columns (IAC) Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Aflatoxin M1 Immunoaffinity Columns (IAC) Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Aflatoxin M1 Immunoaffinity Columns (IAC) Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Aflatoxin M1 Immunoaffinity Columns (IAC) Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Aflatoxin M1 Immunoaffinity Columns (IAC) Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Aflatoxin M1 Immunoaffinity Columns (IAC) Sales and Revenue by Type (2020-2031)
9.4 Central and South America Aflatoxin M1 Immunoaffinity Columns (IAC) Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Aflatoxin M1 Immunoaffinity Columns (IAC) Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Aflatoxin M1 Immunoaffinity Columns (IAC) Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Aflatoxin M1 Immunoaffinity Columns (IAC) Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Aflatoxin M1 Immunoaffinity Columns (IAC) Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Gold Standard Diagnostics Horsham
11.1.1 Gold Standard Diagnostics Horsham Corporation Information
11.1.2 Gold Standard Diagnostics Horsham Business Overview
11.1.3 Gold Standard Diagnostics Horsham Aflatoxin M1 Immunoaffinity Columns (IAC) Product Models, Descriptions and Specifications
11.1.4 Gold Standard Diagnostics Horsham Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Gold Standard Diagnostics Horsham Aflatoxin M1 Immunoaffinity Columns (IAC) Sales by Product in 2024
11.1.6 Gold Standard Diagnostics Horsham Aflatoxin M1 Immunoaffinity Columns (IAC) Sales by Application in 2024
11.1.7 Gold Standard Diagnostics Horsham Aflatoxin M1 Immunoaffinity Columns (IAC) Sales by Geographic Area in 2024
11.1.8 Gold Standard Diagnostics Horsham Aflatoxin M1 Immunoaffinity Columns (IAC) SWOT Analysis
11.1.9 Gold Standard Diagnostics Horsham Recent Developments
11.2 LCTech
11.2.1 LCTech Corporation Information
11.2.2 LCTech Business Overview
11.2.3 LCTech Aflatoxin M1 Immunoaffinity Columns (IAC) Product Models, Descriptions and Specifications
11.2.4 LCTech Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 LCTech Aflatoxin M1 Immunoaffinity Columns (IAC) Sales by Product in 2024
11.2.6 LCTech Aflatoxin M1 Immunoaffinity Columns (IAC) Sales by Application in 2024
11.2.7 LCTech Aflatoxin M1 Immunoaffinity Columns (IAC) Sales by Geographic Area in 2024
11.2.8 LCTech Aflatoxin M1 Immunoaffinity Columns (IAC) SWOT Analysis
11.2.9 LCTech Recent Developments
11.3 Shimadzu
11.3.1 Shimadzu Corporation Information
11.3.2 Shimadzu Business Overview
11.3.3 Shimadzu Aflatoxin M1 Immunoaffinity Columns (IAC) Product Models, Descriptions and Specifications
11.3.4 Shimadzu Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Shimadzu Aflatoxin M1 Immunoaffinity Columns (IAC) Sales by Product in 2024
11.3.6 Shimadzu Aflatoxin M1 Immunoaffinity Columns (IAC) Sales by Application in 2024
11.3.7 Shimadzu Aflatoxin M1 Immunoaffinity Columns (IAC) Sales by Geographic Area in 2024
11.3.8 Shimadzu Aflatoxin M1 Immunoaffinity Columns (IAC) SWOT Analysis
11.3.9 Shimadzu Recent Developments
11.4 Biotez Berlin
11.4.1 Biotez Berlin Corporation Information
11.4.2 Biotez Berlin Business Overview
11.4.3 Biotez Berlin Aflatoxin M1 Immunoaffinity Columns (IAC) Product Models, Descriptions and Specifications
11.4.4 Biotez Berlin Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Biotez Berlin Aflatoxin M1 Immunoaffinity Columns (IAC) Sales by Product in 2024
11.4.6 Biotez Berlin Aflatoxin M1 Immunoaffinity Columns (IAC) Sales by Application in 2024
11.4.7 Biotez Berlin Aflatoxin M1 Immunoaffinity Columns (IAC) Sales by Geographic Area in 2024
11.4.8 Biotez Berlin Aflatoxin M1 Immunoaffinity Columns (IAC) SWOT Analysis
11.4.9 Biotez Berlin Recent Developments
11.5 PerkinElmer
11.5.1 PerkinElmer Corporation Information
11.5.2 PerkinElmer Business Overview
11.5.3 PerkinElmer Aflatoxin M1 Immunoaffinity Columns (IAC) Product Models, Descriptions and Specifications
11.5.4 PerkinElmer Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 PerkinElmer Aflatoxin M1 Immunoaffinity Columns (IAC) Sales by Product in 2024
11.5.6 PerkinElmer Aflatoxin M1 Immunoaffinity Columns (IAC) Sales by Application in 2024
11.5.7 PerkinElmer Aflatoxin M1 Immunoaffinity Columns (IAC) Sales by Geographic Area in 2024
11.5.8 PerkinElmer Aflatoxin M1 Immunoaffinity Columns (IAC) SWOT Analysis
11.5.9 PerkinElmer Recent Developments
11.6 VICAM
11.6.1 VICAM Corporation Information
11.6.2 VICAM Business Overview
11.6.3 VICAM Aflatoxin M1 Immunoaffinity Columns (IAC) Product Models, Descriptions and Specifications
11.6.4 VICAM Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 VICAM Recent Developments
11.7 Ring Biotechnology
11.7.1 Ring Biotechnology Corporation Information
11.7.2 Ring Biotechnology Business Overview
11.7.3 Ring Biotechnology Aflatoxin M1 Immunoaffinity Columns (IAC) Product Models, Descriptions and Specifications
11.7.4 Ring Biotechnology Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Ring Biotechnology Recent Developments
11.8 R-Biopharm AG
11.8.1 R-Biopharm AG Corporation Information
11.8.2 R-Biopharm AG Business Overview
11.8.3 R-Biopharm AG Aflatoxin M1 Immunoaffinity Columns (IAC) Product Models, Descriptions and Specifications
11.8.4 R-Biopharm AG Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 R-Biopharm AG Recent Developments
11.9 CHROMATIFIC
11.9.1 CHROMATIFIC Corporation Information
11.9.2 CHROMATIFIC Business Overview
11.9.3 CHROMATIFIC Aflatoxin M1 Immunoaffinity Columns (IAC) Product Models, Descriptions and Specifications
11.9.4 CHROMATIFIC Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 CHROMATIFIC Recent Developments
11.10 Neogen
11.10.1 Neogen Corporation Information
11.10.2 Neogen Business Overview
11.10.3 Neogen Aflatoxin M1 Immunoaffinity Columns (IAC) Product Models, Descriptions and Specifications
11.10.4 Neogen Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Neogen Recent Developments
11.11 Kwinbon Biotechnology
11.11.1 Kwinbon Biotechnology Corporation Information
11.11.2 Kwinbon Biotechnology Business Overview
11.11.3 Kwinbon Biotechnology Aflatoxin M1 Immunoaffinity Columns (IAC) Product Models, Descriptions and Specifications
11.11.4 Kwinbon Biotechnology Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Kwinbon Biotechnology Recent Developments
11.12 Shandong Meizheng Bio-Tech
11.12.1 Shandong Meizheng Bio-Tech Corporation Information
11.12.2 Shandong Meizheng Bio-Tech Business Overview
11.12.3 Shandong Meizheng Bio-Tech Aflatoxin M1 Immunoaffinity Columns (IAC) Product Models, Descriptions and Specifications
11.12.4 Shandong Meizheng Bio-Tech Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Shandong Meizheng Bio-Tech Recent Developments
11.13 Jiangsu Wisdom Engineering & Technology
11.13.1 Jiangsu Wisdom Engineering & Technology Corporation Information
11.13.2 Jiangsu Wisdom Engineering & Technology Business Overview
11.13.3 Jiangsu Wisdom Engineering & Technology Aflatoxin M1 Immunoaffinity Columns (IAC) Product Models, Descriptions and Specifications
11.13.4 Jiangsu Wisdom Engineering & Technology Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Jiangsu Wisdom Engineering & Technology Recent Developments
11.14 BIOCOMMA
11.14.1 BIOCOMMA Corporation Information
11.14.2 BIOCOMMA Business Overview
11.14.3 BIOCOMMA Aflatoxin M1 Immunoaffinity Columns (IAC) Product Models, Descriptions and Specifications
11.14.4 BIOCOMMA Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 BIOCOMMA Recent Developments
11.15 Beijing Nano-Ace Technology
11.15.1 Beijing Nano-Ace Technology Corporation Information
11.15.2 Beijing Nano-Ace Technology Business Overview
11.15.3 Beijing Nano-Ace Technology Aflatoxin M1 Immunoaffinity Columns (IAC) Product Models, Descriptions and Specifications
11.15.4 Beijing Nano-Ace Technology Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Beijing Nano-Ace Technology Recent Developments
11.16 Femdetection
11.16.1 Femdetection Corporation Information
11.16.2 Femdetection Business Overview
11.16.3 Femdetection Aflatoxin M1 Immunoaffinity Columns (IAC) Product Models, Descriptions and Specifications
11.16.4 Femdetection Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 Femdetection Recent Developments
11.17 Wuhan Huamei Wisherkon Biotech
11.17.1 Wuhan Huamei Wisherkon Biotech Corporation Information
11.17.2 Wuhan Huamei Wisherkon Biotech Business Overview
11.17.3 Wuhan Huamei Wisherkon Biotech Aflatoxin M1 Immunoaffinity Columns (IAC) Product Models, Descriptions and Specifications
11.17.4 Wuhan Huamei Wisherkon Biotech Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 Wuhan Huamei Wisherkon Biotech Recent Developments
11.18 Changsha Huaxue Biological Technology
11.18.1 Changsha Huaxue Biological Technology Corporation Information
11.18.2 Changsha Huaxue Biological Technology Business Overview
11.18.3 Changsha Huaxue Biological Technology Aflatoxin M1 Immunoaffinity Columns (IAC) Product Models, Descriptions and Specifications
11.18.4 Changsha Huaxue Biological Technology Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Price, Revenue and Gross Margin (2020-2025)
11.18.5 Changsha Huaxue Biological Technology Recent Developments
11.19 Anavo
11.19.1 Anavo Corporation Information
11.19.2 Anavo Business Overview
11.19.3 Anavo Aflatoxin M1 Immunoaffinity Columns (IAC) Product Models, Descriptions and Specifications
11.19.4 Anavo Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Price, Revenue and Gross Margin (2020-2025)
11.19.5 Anavo Recent Developments
11.20 Shandong Vnya Bio-technology
11.20.1 Shandong Vnya Bio-technology Corporation Information
11.20.2 Shandong Vnya Bio-technology Business Overview
11.20.3 Shandong Vnya Bio-technology Aflatoxin M1 Immunoaffinity Columns (IAC) Product Models, Descriptions and Specifications
11.20.4 Shandong Vnya Bio-technology Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Price, Revenue and Gross Margin (2020-2025)
11.20.5 Shandong Vnya Bio-technology Recent Developments
11.21 Guanyibio
11.21.1 Guanyibio Corporation Information
11.21.2 Guanyibio Business Overview
11.21.3 Guanyibio Aflatoxin M1 Immunoaffinity Columns (IAC) Product Models, Descriptions and Specifications
11.21.4 Guanyibio Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Price, Revenue and Gross Margin (2020-2025)
11.21.5 Guanyibio Recent Developments
11.22 Prufunglab
11.22.1 Prufunglab Corporation Information
11.22.2 Prufunglab Business Overview
11.22.3 Prufunglab Aflatoxin M1 Immunoaffinity Columns (IAC) Product Models, Descriptions and Specifications
11.22.4 Prufunglab Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Price, Revenue and Gross Margin (2020-2025)
11.22.5 Prufunglab Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Aflatoxin M1 Immunoaffinity Columns (IAC) Industry Chain
12.2 Aflatoxin M1 Immunoaffinity Columns (IAC) Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Aflatoxin M1 Immunoaffinity Columns (IAC) Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Aflatoxin M1 Immunoaffinity Columns (IAC) Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Aflatoxin M1 Immunoaffinity Columns (IAC) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales by Region (2020-2025) & (K Units)
Table 8. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Share by Manufacturers (2020-2025)
Table 12. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Aflatoxin M1 Immunoaffinity Columns (IAC) by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aflatoxin M1 Immunoaffinity Columns (IAC) as of 2024)
Table 16. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Aflatoxin M1 Immunoaffinity Columns (IAC) Manufacturing Base and Headquarters
Table 19. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales by Type (2020-2025) & (K Units)
Table 23. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales by Type (2026-2031) & (K Units)
Table 24. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Aflatoxin M1 Immunoaffinity Columns (IAC) ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales by Application (2020-2025) & (K Units)
Table 29. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales by Application (2026-2031) & (K Units)
Table 30. Aflatoxin M1 Immunoaffinity Columns (IAC) High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Aflatoxin M1 Immunoaffinity Columns (IAC) ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Aflatoxin M1 Immunoaffinity Columns (IAC) Growth Accelerators and Market Barriers
Table 37. North America Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Aflatoxin M1 Immunoaffinity Columns (IAC) Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Aflatoxin M1 Immunoaffinity Columns (IAC) Growth Accelerators and Market Barriers
Table 40. Europe Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Aflatoxin M1 Immunoaffinity Columns (IAC) Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Aflatoxin M1 Immunoaffinity Columns (IAC) Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Aflatoxin M1 Immunoaffinity Columns (IAC) Growth Accelerators and Market Barriers
Table 45. Southeast Asia Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Aflatoxin M1 Immunoaffinity Columns (IAC) Investment Opportunities and Key Challenges
Table 47. Central and South America Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Aflatoxin M1 Immunoaffinity Columns (IAC) Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Gold Standard Diagnostics Horsham Corporation Information
Table 51. Gold Standard Diagnostics Horsham Description and Major Businesses
Table 52. Gold Standard Diagnostics Horsham Product Models, Descriptions and Specifications
Table 53. Gold Standard Diagnostics Horsham Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Gold Standard Diagnostics Horsham Sales Value Proportion by Product in 2024
Table 55. Gold Standard Diagnostics Horsham Sales Value Proportion by Application in 2024
Table 56. Gold Standard Diagnostics Horsham Sales Value Proportion by Geographic Area in 2024
Table 57. Gold Standard Diagnostics Horsham Aflatoxin M1 Immunoaffinity Columns (IAC) SWOT Analysis
Table 58. Gold Standard Diagnostics Horsham Recent Developments
Table 59. LCTech Corporation Information
Table 60. LCTech Description and Major Businesses
Table 61. LCTech Product Models, Descriptions and Specifications
Table 62. LCTech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. LCTech Sales Value Proportion by Product in 2024
Table 64. LCTech Sales Value Proportion by Application in 2024
Table 65. LCTech Sales Value Proportion by Geographic Area in 2024
Table 66. LCTech Aflatoxin M1 Immunoaffinity Columns (IAC) SWOT Analysis
Table 67. LCTech Recent Developments
Table 68. Shimadzu Corporation Information
Table 69. Shimadzu Description and Major Businesses
Table 70. Shimadzu Product Models, Descriptions and Specifications
Table 71. Shimadzu Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Shimadzu Sales Value Proportion by Product in 2024
Table 73. Shimadzu Sales Value Proportion by Application in 2024
Table 74. Shimadzu Sales Value Proportion by Geographic Area in 2024
Table 75. Shimadzu Aflatoxin M1 Immunoaffinity Columns (IAC) SWOT Analysis
Table 76. Shimadzu Recent Developments
Table 77. Biotez Berlin Corporation Information
Table 78. Biotez Berlin Description and Major Businesses
Table 79. Biotez Berlin Product Models, Descriptions and Specifications
Table 80. Biotez Berlin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Biotez Berlin Sales Value Proportion by Product in 2024
Table 82. Biotez Berlin Sales Value Proportion by Application in 2024
Table 83. Biotez Berlin Sales Value Proportion by Geographic Area in 2024
Table 84. Biotez Berlin Aflatoxin M1 Immunoaffinity Columns (IAC) SWOT Analysis
Table 85. Biotez Berlin Recent Developments
Table 86. PerkinElmer Corporation Information
Table 87. PerkinElmer Description and Major Businesses
Table 88. PerkinElmer Product Models, Descriptions and Specifications
Table 89. PerkinElmer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. PerkinElmer Sales Value Proportion by Product in 2024
Table 91. PerkinElmer Sales Value Proportion by Application in 2024
Table 92. PerkinElmer Sales Value Proportion by Geographic Area in 2024
Table 93. PerkinElmer Aflatoxin M1 Immunoaffinity Columns (IAC) SWOT Analysis
Table 94. PerkinElmer Recent Developments
Table 95. VICAM Corporation Information
Table 96. VICAM Description and Major Businesses
Table 97. VICAM Product Models, Descriptions and Specifications
Table 98. VICAM Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. VICAM Recent Developments
Table 100. Ring Biotechnology Corporation Information
Table 101. Ring Biotechnology Description and Major Businesses
Table 102. Ring Biotechnology Product Models, Descriptions and Specifications
Table 103. Ring Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Ring Biotechnology Recent Developments
Table 105. R-Biopharm AG Corporation Information
Table 106. R-Biopharm AG Description and Major Businesses
Table 107. R-Biopharm AG Product Models, Descriptions and Specifications
Table 108. R-Biopharm AG Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. R-Biopharm AG Recent Developments
Table 110. CHROMATIFIC Corporation Information
Table 111. CHROMATIFIC Description and Major Businesses
Table 112. CHROMATIFIC Product Models, Descriptions and Specifications
Table 113. CHROMATIFIC Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. CHROMATIFIC Recent Developments
Table 115. Neogen Corporation Information
Table 116. Neogen Description and Major Businesses
Table 117. Neogen Product Models, Descriptions and Specifications
Table 118. Neogen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Neogen Recent Developments
Table 120. Kwinbon Biotechnology Corporation Information
Table 121. Kwinbon Biotechnology Description and Major Businesses
Table 122. Kwinbon Biotechnology Product Models, Descriptions and Specifications
Table 123. Kwinbon Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Kwinbon Biotechnology Recent Developments
Table 125. Shandong Meizheng Bio-Tech Corporation Information
Table 126. Shandong Meizheng Bio-Tech Description and Major Businesses
Table 127. Shandong Meizheng Bio-Tech Product Models, Descriptions and Specifications
Table 128. Shandong Meizheng Bio-Tech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Shandong Meizheng Bio-Tech Recent Developments
Table 130. Jiangsu Wisdom Engineering & Technology Corporation Information
Table 131. Jiangsu Wisdom Engineering & Technology Description and Major Businesses
Table 132. Jiangsu Wisdom Engineering & Technology Product Models, Descriptions and Specifications
Table 133. Jiangsu Wisdom Engineering & Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Jiangsu Wisdom Engineering & Technology Recent Developments
Table 135. BIOCOMMA Corporation Information
Table 136. BIOCOMMA Description and Major Businesses
Table 137. BIOCOMMA Product Models, Descriptions and Specifications
Table 138. BIOCOMMA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. BIOCOMMA Recent Developments
Table 140. Beijing Nano-Ace Technology Corporation Information
Table 141. Beijing Nano-Ace Technology Description and Major Businesses
Table 142. Beijing Nano-Ace Technology Product Models, Descriptions and Specifications
Table 143. Beijing Nano-Ace Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. Beijing Nano-Ace Technology Recent Developments
Table 145. Femdetection Corporation Information
Table 146. Femdetection Description and Major Businesses
Table 147. Femdetection Product Models, Descriptions and Specifications
Table 148. Femdetection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 149. Femdetection Recent Developments
Table 150. Wuhan Huamei Wisherkon Biotech Corporation Information
Table 151. Wuhan Huamei Wisherkon Biotech Description and Major Businesses
Table 152. Wuhan Huamei Wisherkon Biotech Product Models, Descriptions and Specifications
Table 153. Wuhan Huamei Wisherkon Biotech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 154. Wuhan Huamei Wisherkon Biotech Recent Developments
Table 155. Changsha Huaxue Biological Technology Corporation Information
Table 156. Changsha Huaxue Biological Technology Description and Major Businesses
Table 157. Changsha Huaxue Biological Technology Product Models, Descriptions and Specifications
Table 158. Changsha Huaxue Biological Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 159. Changsha Huaxue Biological Technology Recent Developments
Table 160. Anavo Corporation Information
Table 161. Anavo Description and Major Businesses
Table 162. Anavo Product Models, Descriptions and Specifications
Table 163. Anavo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 164. Anavo Recent Developments
Table 165. Shandong Vnya Bio-technology Corporation Information
Table 166. Shandong Vnya Bio-technology Description and Major Businesses
Table 167. Shandong Vnya Bio-technology Product Models, Descriptions and Specifications
Table 168. Shandong Vnya Bio-technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 169. Shandong Vnya Bio-technology Recent Developments
Table 170. Guanyibio Corporation Information
Table 171. Guanyibio Description and Major Businesses
Table 172. Guanyibio Product Models, Descriptions and Specifications
Table 173. Guanyibio Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 174. Guanyibio Recent Developments
Table 175. Prufunglab Corporation Information
Table 176. Prufunglab Description and Major Businesses
Table 177. Prufunglab Product Models, Descriptions and Specifications
Table 178. Prufunglab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 179. Prufunglab Recent Developments
Table 180. Key Raw Materials Distribution
Table 181. Raw Materials Key Suppliers
Table 182. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 183. Milestones in Production Technology Evolution
Table 184. Distributors List
Table 185. Market Trends and Market Evolution
Table 186. Market Drivers and Opportunities
Table 187. Market Challenges, Risks, and Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Aflatoxin M1 Immunoaffinity Columns (IAC) Product Picture
Figure 2. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. 80% Below Product Picture
Figure 4. 80-90% Product Picture
Figure 5. 91-100% Product Picture
Figure 6. 100% Above Product Picture
Figure 7. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Milk
Figure 9. Goat Milk
Figure 10. Soy Milk
Figure 11. Others
Figure 12. Aflatoxin M1 Immunoaffinity Columns (IAC) Report Years Considered
Figure 13. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue (2020-2031) & (US$ Million)
Figure 15. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 16. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue Market Share by Region (2020-2031)
Figure 17. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales (2020-2031) & (K Units)
Figure 18. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales (CAGR) by Region (2020-2031) (K Units)
Figure 19. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Market Share by Region (2020-2031)
Figure 20. Top 5 and Top 10 Manufacturers Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume Market Share in 2024
Figure 21. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue Market Share Ranking (2024)
Figure 22. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 23. 80% Below Revenue Market Share by Manufacturer in 2024
Figure 24. 80-90% Revenue Market Share by Manufacturer in 2024
Figure 25. 91-100% Revenue Market Share by Manufacturer in 2024
Figure 26. 100% Above Revenue Market Share by Manufacturer in 2024
Figure 27. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Market Share by Type (2020-2031)
Figure 28. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue Market Share by Type (2020-2031)
Figure 29. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Market Share by Application (2020-2031)
Figure 30. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue Market Share by Application (2020-2031)
Figure 31. North America Aflatoxin M1 Immunoaffinity Columns (IAC) Sales YoY (2020-2031) & (K Units)
Figure 32. North America Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue YoY (2020-2031) & (US$ Million)
Figure 33. North America Top 5 Manufacturers Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Revenue (US$ Million) in 2024
Figure 34. North America Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume (K Units) by Type (2020- 2031)
Figure 35. North America Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 36. North America Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume (K Units) by Application (2020-2031)
Figure 37. North America Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Revenue (US$ Million) by Application (2020-2031)
Figure 38. US Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue (2020-2031) & (US$ Million)
Figure 39. Canada Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue (2020-2031) & (US$ Million)
Figure 40. Mexico Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue (2020-2031) & (US$ Million)
Figure 41. Europe Aflatoxin M1 Immunoaffinity Columns (IAC) Sales YoY (2020-2031) & (K Units)
Figure 42. Europe Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue YoY (2020-2031) & (US$ Million)
Figure 43. Europe Top 5 Manufacturers Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Revenue (US$ Million) in 2024
Figure 44. Europe Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume (K Units) by Type (2020-2031)
Figure 45. Europe Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Revenue (US$ Million) by Type (2020-2031)
Figure 46. Europe Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume (K Units) by Application (2020-2031)
Figure 47. Europe Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Revenue (US$ Million) by Application (2020-2031)
Figure 48. Germany Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue (2020-2031) & (US$ Million)
Figure 49. France Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue (2020-2031) & (US$ Million)
Figure 50. U.K. Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue (2020-2031) & (US$ Million)
Figure 51. Italy Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue (2020-2031) & (US$ Million)
Figure 52. Russia Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue (2020-2031) & (US$ Million)
Figure 53. Asia-Pacific Aflatoxin M1 Immunoaffinity Columns (IAC) Sales YoY (2020-2031) & (K Units)
Figure 54. Asia-Pacific Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue YoY (2020-2031) & (US$ Million)
Figure 55. Asia-Pacific Top 8 Manufacturers Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Revenue (US$ Million) in 2024
Figure 56. Asia-Pacific Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume (K Units) by Type (2020- 2031)
Figure 57. Asia-Pacific Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 58. Asia-Pacific Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume (K Units) by Application (2020-2031)
Figure 59. Asia-Pacific Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Revenue (US$ Million) by Application (2020-2031)
Figure 60. Indonesia Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue (2020-2031) & (US$ Million)
Figure 61. Japan Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue (2020-2031) & (US$ Million)
Figure 62. South Korea Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue (2020-2031) & (US$ Million)
Figure 63. China Taiwan Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue (2020-2031) & (US$ Million)
Figure 64. India Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue (2020-2031) & (US$ Million)
Figure 65. Central and South America Aflatoxin M1 Immunoaffinity Columns (IAC) Sales YoY (2020-2031) & (K Units)
Figure 66. Central and South America Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue YoY (2020-2031) & (US$ Million)
Figure 67. Central and South America Top 5 Manufacturers Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Revenue (US$ Million) in 2024
Figure 68. Central and South America Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume (K Units) by Type (2021-2031)
Figure 69. Central and South America Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Revenue (US$ Million) by Type (2020-2031)
Figure 70. Central and South America Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume (K Units) by Application (2020-2031)
Figure 71. Central and South America Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Revenue (US$ Million) by Application (2020-2031)
Figure 72. Brazil Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue (2020-2025) & (US$ Million)
Figure 73. Argentina Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue (2020-2025) & (US$ Million)
Figure 74. Middle East, and Africa Aflatoxin M1 Immunoaffinity Columns (IAC) Sales YoY (2020-2031) & (K Units)
Figure 75. Middle East and Africa Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue YoY (2020-2031) & (US$ Million)
Figure 76. Middle East and Africa Top 5 Manufacturers Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Revenue (US$ Million) in 2024
Figure 77. Middle East and Africa Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume (K Units) by Type (2021-2031)
Figure 78. South America Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Revenue (US$ Million) by Type (2020-2031)
Figure 79. Middle East and Africa Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume (K Units) by Application (2020-2031)
Figure 80. Middle East and Africa Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Revenue (US$ Million) by Application (2020-2031)
Figure 81. GCC Countries Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue (2020-2025) & (US$ Million)
Figure 82. Turkey Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue (2020-2025) & (US$ Million)
Figure 83. Egypt Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue (2020-2025) & (US$ Million)
Figure 84. South Africa Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue (2020-2025) & (US$ Million)
Figure 85. Aflatoxin M1 Immunoaffinity Columns (IAC) Industry Chain Mapping
Figure 86. Regional Aflatoxin M1 Immunoaffinity Columns (IAC) Manufacturing Base Distribution (%)
Figure 87. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Production Market Share by Region (2020-2031)
Figure 88. Aflatoxin M1 Immunoaffinity Columns (IAC) Production Process
Figure 89. Regional Aflatoxin M1 Immunoaffinity Columns (IAC) Production Cost Structure
Figure 90. Channels of Distribution (Direct Vs Distribution)
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Aflatoxin M1 Immunoaffinity Columns (IAC) market?
The top companies in the global Aflatoxin M1 Immunoaffinity Columns (IAC) market are Gold Standard Diagnostics Horsham、LCTech、Shimadzu.
Related Reports
Aflatoxin M1 Immunoaffinity Columns (IAC)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Aflatoxin M1 Immunoaffinity Columns (IAC) was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-02-11
Pages: 159
USD 3950.00
(Single User License)
Global Aflatoxin M1 Immunoaffinity Columns (IAC) Market Research Report 2026
The global Aflatoxin M1 Immunoaffinity Columns (IAC) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-02-11
Pages: 145
USD 2900.00
(Single User License)
Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Aflatoxin M1 Immunoaffinity Columns (IAC) market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 120
USD 4250.00
(Single User License)
Aflatoxin M1 Immunoaffinity Columns (IAC)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Aflatoxin M1 Immunoaffinity Columns (IAC) was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-03
Pages: 168
USD 3950.00
(Single User License)
Global Aflatoxin M1 Immunoaffinity Columns (IAC) Market Research Report 2025
The global market for Aflatoxin M1 Immunoaffinity Columns (IAC) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-03
Pages: 109
USD 2900.00
(Single User License)
Global Aflatoxin M1 Immunoaffinity Columns (IAC) Market Insights, Forecast to 2030
Aflatoxin B1 Immunoaffinity Columns (IACs) are specialized chromatographic columns designed specifically for the extraction and purification of aflatoxin B1 (AFB1) from various samples. AFB1 is one of the most significant and toxic aflatoxins produced by certain molds, particularly Aspergillus flavus and Aspergillus parasiticus.
Published Date: 2024-04-25
Pages: 128
USD 4900.00
(Single User License)
Aflatoxin M1 Immunoaffinity Columns (IAC) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Aflatoxin B1 Immunoaffinity Columns (IACs) are specialized chromatographic columns designed specifically for the extraction and purification of aflatoxin B1 (AFB1) from various samples. AFB1 is one of the most significant and toxic aflatoxins produced by certain molds, particularly Aspergillus flavus and Aspergillus parasiticus.
Published Date: 2024-02-22
Pages: 162
USD 3950.00
(Single User License)
Aflatoxin M1 Immunoaffinity Columns (IAC)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Aflatoxin M1 Immunoaffinity Columns (IAC) was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-02-11
Pages: 159
USD 3950.00 (Single User License)Global Aflatoxin M1 Immunoaffinity Columns (IAC) Market Research Report 2026
The global Aflatoxin M1 Immunoaffinity Columns (IAC) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-02-11
Pages: 145
USD 2900.00 (Single User License)Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Aflatoxin M1 Immunoaffinity Columns (IAC) market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 120
USD 4250.00 (Single User License)Aflatoxin M1 Immunoaffinity Columns (IAC)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Aflatoxin M1 Immunoaffinity Columns (IAC) was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-03
Pages: 168
USD 3950.00 (Single User License)Global Aflatoxin M1 Immunoaffinity Columns (IAC) Market Research Report 2025
The global market for Aflatoxin M1 Immunoaffinity Columns (IAC) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-03
Pages: 109
USD 2900.00 (Single User License)Global Aflatoxin M1 Immunoaffinity Columns (IAC) Market Insights, Forecast to 2030
Aflatoxin B1 Immunoaffinity Columns (IACs) are specialized chromatographic columns designed specifically for the extraction and purification of aflatoxin B1 (AFB1) from various samples. AFB1 is one of the most significant and toxic aflatoxins produced by certain molds, particularly Aspergillus flavus and Aspergillus parasiticus.
Published: 2024-04-25
Pages: 128
USD 4900.00 (Single User License)Aflatoxin M1 Immunoaffinity Columns (IAC) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Aflatoxin B1 Immunoaffinity Columns (IACs) are specialized chromatographic columns designed specifically for the extraction and purification of aflatoxin B1 (AFB1) from various samples. AFB1 is one of the most significant and toxic aflatoxins produced by certain molds, particularly Aspergillus flavus and Aspergillus parasiticus.
Published: 2024-02-22
Pages: 162
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now